Oppenheimer Lowers UnitedHealth Group (NYSE:UNH) Price Target to $600.00

UnitedHealth Group (NYSE:UNH - Free Report) had its price objective cut by Oppenheimer from $640.00 to $600.00 in a research report report published on Monday,Benzinga reports. They currently have an outperform rating on the healthcare conglomerate's stock.

Other analysts have also issued reports about the company. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays cut their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a report on Friday, January 17th. Mizuho upped their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Truist Financial boosted their target price on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Finally, KeyCorp reissued an "overweight" rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Buy" and a consensus target price of $603.05.

UnitedHealth Group Trading Down 0.8 %

Shares of UNH stock traded down $3.26 during mid-day trading on Monday, hitting $424.70. The company's stock had a trading volume of 7,608,478 shares, compared to its average volume of 4,452,390. The company's fifty day simple moving average is $506.92 and its 200-day simple moving average is $537.23. UnitedHealth Group has a 52 week low of $417.12 and a 52 week high of $630.73. The company has a market cap of $388.48 billion, a PE ratio of 27.40, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the business earned $6.91 EPS. As a group, equities research analysts expect that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.98%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. NewSquare Capital LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter worth approximately $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $28,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group during the 4th quarter worth about $30,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.